Market News

NYSE:HCA News

10 stories
stockstory

HCA Healthcare’s (NYSE:HCA) Q2 CY2026 Sales Top Estimates

Hospital operator HCA Healthcare NYSE:HCA reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 8.7% year on year to $20.23 billion. The company expects the full year’s revenue to be around $78.25 billion, close to analysts’ estimates. Its GAAP profit of $7.62 per sh…

Stock Story en
StocksUS
business_wire

NYSE: HCA Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages HCA Healthcare, Inc. (NYSE: HCA) Investors to Contact the Firm

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by HCA Healthcare, Inc. (NYSE: HCA) on behalf of investors who purchased or acquired HCA Healthcare, Inc. securities and ex…

BusinessWire en
StocksUS
tradingview

HCA Q3'26 Earnings: revenue estimate is 19.61B USD

HCA (HCA Healthcare, Inc.) is set to announce its Q3'26 results on October 23, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 19.61 billion USD with EPS (earnings per share) anticipated at 7.13 USD. Learn more details at HCA…

TradingView en
StocksUS
stockstory

Why HCA Healthcare (HCA) Stock Is Trading Lower Today

What Happened? Shares of hospital operator HCA Healthcare NYSE:HCAfell 6.7% in the morning session after the company released preliminary second-quarter results and cut its full-year 2026 profit guidance.The company attributed the lowered forecast to a shift in its "payer mix," which means it treat…

Stock Story en
StocksUS
zacks

Can HCA's Gene Therapy Milestone Drive Long-Term Growth?

HCA Healthcare, Inc. HCA is expanding its presence in advanced medicine after researchers from its Sarah Cannon Transplant and Cellular Therapy Program published encouraging findings in The New England Journal of Medicine. The study found that the CRISPR gene-editing therapy, exa-cel, successfully…

Zacks en
StocksUS